Reliable Data You Can Trust
Reliable Data You Can Trust
A recent report published by Infinium Global Research on drug eluting balloon market provides an in-depth analysis of segments and sub-segments in the global as well as regional drug eluting balloon market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional drug eluting balloon market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global drug eluting balloon market. According to the report, the global drug eluting balloon market is projected to grow at a CAGR of 19% over the forecast period of 2018-2024.
Drug eluting balloons (DEB) are a conservative semi-compliant angioplasty balloon that is covered with an anti-proliferative drug. The (DE) balloon is inserted into the blocked artery and left for a few minutes. The drug is discharged into the vessel wall at the time of inflation of the balloon, and at minimal pressures with a minimal inflation time. Minor surgeries and open-heart surgeries can be threatening to life as they contain numerous difficulties. The surgeon adopts MI techniques over traditional techniques as they assure faster recovery, reduced hospital stays negligible obstacles and high accuracy. Drug eluting balloons also play an important role in the treatment of coronary artery disease.
Growing geriatric population and rising incidence of peripheral artery diseases (PAD) worldwide are major factors driving the growth for drug eluting balloon market. Coronary artery disease occurs when the arteries that supply blood to the heart muscle become narrow or hard owing to the accumulation of cholesterol and other resources on the inner walls. Hence, this results in deficient oxygen and blood flow and can lead to chest pain or heart attack. Coronary artery diseases also fail the heart muscle and can lead to heart failure and arrhythmias thus, the growing prevalence for coronary artery diseases is another factor driving the growth of the market. Besides, drug eluting balloon is gaining acceptance amongst surgeons, as they are effective for the treatment of peripheral artery and coronary artery diseases. This balloon decreases the risk of stent failure is more effective in the treatment of superficial femoral artery (SFA). Increase in R&D activities supported by government policies is anticipated to generate an opportunity for coming years. On the other side, long-governing approval procedure, and major investment required owing to the high erosion rate in clinical trials are likely to hamper the market growth for drug eluting balloon market.
Among the geographies, North America holds a significant share in drug eluting balloon market. Owing to increasing awareness regarding therapeutic applications of drug eluting balloons in coronary and peripheral artery diseases is driving the growth of the drug eluting balloon market in North America region. Additionally, augmented investments by several foreign medical device companies have also pushed the growth of the drug eluting balloons market in this region.
The report on global drug eluting balloon market covers segments such as product type, end-user, and coating technology. On the basis of product type, the sub-markets include peripheral drug eluting balloon, coronary drug eluting balloon, and others. On the basis of end-user, the sub-markets include cath labs, hospitals, ambulatory surgery centers, and others. On the basis of coating technology, the sub-markets include enduracoat, freepac, paccocath, transpax, and others.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section, the key trends and market size for each geography are provided over the period of 2016-2024. The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region, as it is the largest market in this region. The Asia-Pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China.
The report provides profiles of the companies in the market such as Koninklijke Philips N.V, Eurocor GmbH, Biotronik SE & Co. KG, Boston Scientific Corporation, B. Braun Melsungen AG, Bayer AG, Terumo Corporation, Becton, Dickinson and Company, Cook Medical, Inc., and Medtronic Plc.
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of drug eluting balloon market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.
Please Choose One of them.